XML 35 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 15 - Stock Based Compensation -
12 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note
1
5
– Stock Based Compensation –
 
Equity Incentive Plan
 
The Company previously granted options to its employees under its
2006
Stock Option Plan which expired on
December 22, 2016.
On
June 29, 2017,
the Company
’s shareholders approved its
2017
Equity Incentive Plan (the “Plan”). The Plan provides for the grant of various types of equity grants and awards, including incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock, restricted stock units, performance units, performance shares and other stock-based awards to eligible participants, which includes the Company’s employees, directors and consultants. The Plan has reserved
500,000
shares of common stock for grant, award or issuance to eligible participants, all of which
may
be subject to incentive stock option treatment. The Plan is administered by the Compensation Committee of the Company’s Board of Directors, which determines, within the provisions of the Plan, those eligible participants to whom, and the times at which, grants and awards will be made. As of
December 31, 2017,
no
awards have been granted under the Plan, and
500,000
shares of common stock remain available for grant.
 
Restricted Stock Awards
 
The Company issues restricted stock under various plans for certain officers and other key employees. The restricted stock awards
may
not
be sold or otherwise transferred until certain restrictions have lapsed. The holders of the
restricted stock receive dividends and have full voting rights with respect to those shares as of the date of grant. The compensation expense for these awards is determined based upon the market value of the Company’s common stock at the grant date applied to the total number of shares awarded and is recognized over the vesting period.
 
During the year ended
December 31, 2017,
the Company issued shares of restricted stock which vest in
three
equal installments over a period of
two
years. For the year en
ded
December 31, 2017,
the Company recognized
$129,000
in compensation costs related to restricted stock awards. At
December 31, 2017,
unrecognized share-based compensation associated with these awards totaled
$92,000.
 
The table below summarizes th
e restricted stock award activity for the period presented.
 
   
Year Ended December 31, 201
7
 
           
Weighted Averag
e
 
   
Share
s
   
Grant Date Fair Valu
e
 
Balance, at Beginning of Perio
d
   
-
    $
-
 
Grante
d
   
12,981
     
17.00
 
Forfeite
d
   
-
     
-
 
Earned and Issue
d
   
(4,319
)    
17.00
 
                 
Balance, at End of Perio
d
   
8,662
    $
17.00
 
 
 
Stock Grants
 
During the year ended
December 31, 2017,
the Company issued a total of
4,410
shares of common stock to non-employee directors as inducement to their board service and a total of
1,000
shares of common stock to an employee as inducement to their employment.
The shares vested immediately upon issuance. The total stock-based compensation expense was determined based upon the market value of the Company’s common stock at the grant date applied to the total number of shares granted. Included in directors fees expense and compensation expense was
$75,000
and
$17,000,
respectively, during the year ended
December 31, 2017.
 
Stock Warrants
 
In connection with
the organization of the Company and the Bank, stock warrants were issued to organizers. The warrants
may
be exercised by the holders for the purchase of
101,000
shares of common stock of the Company at the exercise price of
$10
per share (warrant). The warrants were fully vested on
February 1, 2011
and were to expire in
2016.
The warrant agreements were amended effective
February 1, 2016
to extend the expiration time to
February 2, 2019
,
with
$48,000
of compensation cost recognized on the effective date.
 
At
December 31,
201
7
and
2016,
warrants for
87,625
shares at a weighted average exercise price of
$10.00
were outstanding. At
December 31, 2017,
all of the
87,625
outstanding warrants were vested and there was
no
unrecognized compensation. However, the amendment effective
February 1, 2016
extended the exercise period and retained the
$10
per share exercise price. As a result, in compliance
with Section
409A
of the Internal Revenue Code of
1986,
as amended, the “
optionality” of the warrants was eliminated thereby restricting the situations in which the warrants can be exercised to occur upon the earlier of (i) immediately prior to the
February 2, 2019
expiration date, (ii) a change in control of the Company or the Bank, (iii) the warrant holder’s death, (iv) the warrant holder becoming disabled, and (v) the warrant holder incurring a separation from the Company or the Bank (if the warrant holder is an employee of the Company or the Bank).
 
Using the Black-Scholes pricing model for the
8
7,625
shares (warrants) outstanding, the calculated value of
$2.50
per share (warrant) was estimated on the date of grant using the following assumptions: expected dividends of
1%,
expected life or term of
6.5
years, risk-free interest rate of
5.04%,
and expected volatility of
13.19%.
The expected volatility was estimated considering the historical volatility of an appropriate industry sector.
 
Stock Options
 
In
2006,
t
he Company established a stock option plan with
1,500,000
shares available to be granted as options under the plan. Under the provisions of the plan, the option price cannot be less than the fair value of the underlying common stock as of option grant date, and the maximum option term cannot exceed
ten
years. The
2006
Stock Option Plan expired on
December 22, 2016
and the Company is
no
longer permitted to issue additional stock options under this plan.
 
During the year ended
December 31,
201
6,
total options of
50,000
were granted to officers and other key employees. The stock options granted were issued at an exercise price of
$17.65
per share for the year ended
December 31, 2016,
with a vesting period of
three
years. Compensation expense recognized as a result of vesting was approximately
$207,000
and
$240,000
in
2017
and
2016,
respectively.
 
The Company uses the Black-Scholes option pricing
model to estimate the calculated value of the various share-based awards with the following assumptions for the year ended
December 31, 2016.
There were
no
share-based awards for the year ended
December 31, 2017
since the Plan expired
December 22, 2016.
 
   
201
6
 
Risk-Free Interest Rat
e
 
1.36%
 
Expected Dividend Yiel
d
 
1.18%
 
Expected Volatilit
y
 
31.68%
 
Expected Life in Year
s
 
5.0
 
Weighted Average Calculated Value of Options Grante
d
 
$4.27
 
 
The following is an analysis of the activity related to the stock options:
 
   
Yeas Ended December 31,
 
   
2017
   
2016
 
   
Number of
   
Weighted Average
   
Number of
   
Weighted Average
 
   
Options
   
Exercise Price
   
Options
   
Exercise Price
 
Outstanding Options, at Beginning of Period
   
998,480
    $
12.82
     
953,280
    $
12.59
 
Granted
   
-
     
-
     
50,000
     
17.65
 
Exercised
   
-
     
-
     
-
     
-
 
Forfeited or Expired
   
(167,400
)    
13.25
     
(4,800
)    
17.11
 
                                 
Outstanding Options, at End of Period
   
831,080
    $
12.73
     
998,480
    $
12.82
 
                                 
Exerciseable, at End of Period
   
784,698
    $
12.49
     
562,548
    $
13.79
 
 
At
December 31,
2017,
options for
784,698
shares at a weighted average exercise price of
$12.49
were vested and exercisable, and there were
46,382
nonvested options and approximately
$210,000
of unrecognized compensation costs related to these options which is expected to be recognized over a period of
three
years.
 
In
December 2017,
the option agreements were amended for
105,250
options which were fully vested and set to expire in
December 2017
to extend the expiration date to
January 15, 2021.
Compensation cost of the
$63,0
00
was recognized on the effective date of the amendments. On
December 20, 2016
the option agreements were amended for
330,000
options which were fully vested and set to expire
December 22, 2016
to extend the expiration date to
January 15, 2020.
Compensation cost of
$168,000
was recognized on the effective date of the amendments. Since all of these amendments extended the exercise period and retained the original per share exercise price, the “optionality” was eliminated in compliance with Section
409A
of the Internal Revenue Code of
1986,
as amended, thereby restricting the situations in which the options can be exercised to occur upon the earlier of (i) immediately prior to the expiration date, (ii) a change in control of the Company or the Bank, (iii) the option holder’s death, (iv) the option holder becoming disabled, and (v) the option holder incurring a separation from the Company or the Bank (if the option holder is an employee of the Company or the Bank).